Company intelligence / Profile preview

Mach Lab

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Mach Lab is a biotechnology company focused on accelerating drug discovery through the integration of advanced computational modeling and high-throughput experimental validation. The company utilizes an AI-driven platform to identify novel therapeutic targets and optimize lead compounds with a primary focus on oncology and immunology. By bridging the gap between digital simulation and laboratory results, Mach Lab aims to reduce the time and cost associated with early-stage drug development. Their approach emphasizes the discovery of small molecule therapeutics for previously undruggable targets.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeProtein
Industry: Biotech

Beyond the preview

Go deeper on Mach Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mach Lab.

Explore the full profile